![Alexion](https://www.adcreviews.com/wp-content/uploads/2022/10/Alexion-240x96.jpg)
AstraZeneca subsidiary Alexion reaches definitive acquisition agreement with Lexington
On October 3, Alexion, a subsidiary of AstraZeneca’s rare disease business, announced that it had reached a definitive acquisition agreement with Lexington. The acquisition is